Skip to the page

Data / Drug companies / Hart Health

Hart Health: 39 products in the FDA NDC directory, labeler code 50332

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Hart Health (labeler code 50332) lists 39 products in the FDA National Drug Code Directory, covering 27 finished drugs by generic name. By type: 39 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on December 2, 2025.

The request: Watch Hart Health (FDA labeler code 50332): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
50332
Products in commercial distribution
39
Packages
105
Finished drugs by generic name
27
Prescription products
0
Over the counter products
39
Flagged as original packager
39 of 39 products that carry the flag
Started marketing in the last 12 months
1
Earliest marketing start
January 1, 1900
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs3897.4%
Generic drugs (ANDA)12.6%

Products by type

TypeProductsShare
Over the counter drugs39100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Spray717.9%
Tablet615.4%
Swab512.8%
Cream410.3%
Ointment37.7%
Lozenge37.7%
Aerosol, spray25.1%
Tablet, film coated25.1%
Gel25.1%
Solution12.6%
Tablet, chewable12.6%
Tablet, coated12.6%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Tribiotic50332-0095OintmentOver the counter monograph drugsDecember 2, 2025
First Aid and Burn50332-0091CreamOver the counter monograph drugsSeptember 18, 2025
Hand Sanitizer50332-0094GelOver the counter monograph drugsSeptember 17, 2025
Alcohol50332-0223SprayOver the counter monograph drugsAugust 15, 2025
Burn50332-0209SprayOver the counter monograph drugsAugust 15, 2025
Hydrocortisone50332-0092CreamOver the counter monograph drugsAugust 14, 2025
Tribiotic50332-0093OintmentOver the counter monograph drugsAugust 13, 2025
Cetirza50332-0154TabletOver the counter monograph drugsAugust 4, 2025
Exaprin Plus50332-0144Tablet, film coatedOver the counter monograph drugsAugust 4, 2025
Therastat50332-0137LozengeOver the counter monograph drugsAugust 4, 2025
Hydrogen Peroxide50332-0229SprayOver the counter monograph drugsJune 10, 2025
Thoracol50332-0156LozengeOver the counter monograph drugsDecember 9, 2024
Therastat, cherry50332-0157LozengeOver the counter monograph drugsAugust 1, 2024
Burn50332-0210SprayOver the counter monograph drugsJanuary 1, 2024
CETAFEN COUGH and COLD50332-0141Tablet, film coatedOver the counter monograph drugsJanuary 9, 2023
Ibuprofen50332-0152TabletOver the counter monograph drugsJanuary 1, 2023
Histaprin50332-0150TabletOver the counter monograph drugsJanuary 1, 2023
Aspirin50332-0139TabletOver the counter monograph drugsJanuary 1, 2023
Hand Sanitizer50332-0040GelOver the counter monograph drugsJanuary 8, 2021
Proprinal50332-0130Capsule, liquid filledGeneric drugs (ANDA)January 11, 2017
Alcohol50332-0213SprayOver the counter monograph drugsMay 4, 2012
Relief-PE50332-0153Tablet, coatedOver the counter monograph drugsApril 16, 2012
Tribiotic50332-0032OintmentOver the counter monograph drugsOctober 3, 2005
First Aid and Burn50332-0037CreamOver the counter monograph drugsJuly 14, 2000
Sooth-a-Sting50332-0050SwabOver the counter monograph drugsJanuary 1, 2000

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.